Ernexa Therapeutics, Inc. (ERNA)
1.36
-0.27
(-16.56%)
USD |
NASDAQ |
Nov 20, 16:00
1.41
+0.05
(+3.68%)
After-Hours: 20:00
Ernexa Therapeutics Total Liabilities (Quarterly) : 2.753M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 2.753M |
| June 30, 2026 | 3.115M |
| March 31, 2026 | 3.684M |
| December 31, 2025 | 3.433M |
| September 30, 2025 | 2.602M |
| June 30, 2025 | 3.14M |
| March 31, 2025 | 11.01M |
| December 31, 2024 | 3.568M |
| September 30, 2024 | 53.11M |
| June 30, 2024 | 55.01M |
| March 31, 2024 | 53.07M |
| December 31, 2023 | 46.90M |
| September 30, 2023 | 48.69M |
| June 30, 2023 | 43.09M |
| March 31, 2023 | 7.728M |
| December 31, 2022 | 10.17M |
| September 30, 2022 | 12.11M |
| June 30, 2022 | 12.12M |
| March 31, 2022 | 18.06M |
| December 31, 2021 | 6.022M |
| September 30, 2021 | 26.35M |
| June 30, 2021 | 29.53M |
| March 31, 2021 | 25.12M |
| December 31, 2020 | 25.36M |
| September 30, 2020 | 4.559M |
| Date | Value |
|---|---|
| June 30, 2020 | 4.859M |
| March 31, 2020 | 7.165M |
| December 31, 2019 | 10.18M |
| September 30, 2019 | 8.574M |
| June 30, 2019 | 8.972M |
| March 31, 2019 | 9.784M |
| December 31, 2018 | 7.947M |
| September 30, 2018 | 8.648M |
| June 30, 2018 | 9.82M |
| March 31, 2018 | 10.50M |
| December 31, 2017 | 11.03M |
| September 30, 2017 | 11.50M |
| June 30, 2017 | 12.50M |
| March 31, 2017 | 11.71M |
| December 31, 2016 | 13.07M |
| September 30, 2016 | 12.60M |
| June 30, 2016 | 12.67M |
| March 31, 2016 | 13.28M |
| December 31, 2015 | 12.98M |
| September 30, 2015 | 12.50M |
| June 30, 2015 | 11.09M |
| March 31, 2015 | 11.55M |
| December 31, 2014 | 12.02M |
| September 30, 2014 | 9.956M |
| June 30, 2014 | 8.86M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Cerenome, Inc. | 13.12M |
| ACADIA Pharmaceuticals, Inc. | 406.66M |
| Alnylam Pharmaceuticals, Inc. | 4.391B |
| Anika Therapeutics, Inc. | 52.02M |
| Savara, Inc. | 48.08M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.104M |
| Shareholders Equity (Quarterly) | 4.351M |
| Debt to Equity Ratio | 0.071 |
| Current Ratio | 2.574 |
| Net Debt Paydown Yield | 1.08% |